Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trialDavid C. McGiffin, David M. Kaye, S. Emmanuel et al.|The Journal of Heart and Lung Transplantation|2023Cited by 89
Clinical Trial Design of AT-02 Phase 2 Open Label Extension Study in Systemic Amyloidosis PC143 (#519)Spencer Guthrie, Matthew Meldorf, Marianna Fontana et al.|Unknown|2024Cited by 0